.jpg)
.jpg)
01 Apr, 2020
CNS Pharmaceuticals Development Partner, WPD Pharmaceuticals, Reports Active Compound in Licensed Drug Candidate Reduces COVID19 Replication in Vitro by 100%
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) in collaboration with its development partner WPD Pharmaceuticals Inc. intends to develop several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the co..
Samsung to Invest USD 22 Billion on AI, 5G and Biopharmaceuticals
Samsung plans to spend USD 22 Billion in the next three years on developing artificial intelligence, 5G, automotive electronic parts and biopharmaceuticals. This comes as part of the earlier announced USD 160 Billion investment on research, developm..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).